Amantadine Sulphate versus magnesium sulfate on Traumatic Brain Injury.

Comparative Study between the Efficacy of Amantadine Sulphate versus magnesium sulfate on Traumatic Brain Injury. A prospective randomized trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202009761063655

Enrollment

Registered

2020-09-29

Start date

2020-09-02

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Magnesium group

Amantadine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients of both sex aged from (18-65 years) (GCS <_12)

Exclusion criteria

Exclusion criteria: Refusal of patient guardians bleeding disorders severe pre-existing physical or mental disability severe co-morbidity that could interfere with the assessment of outcome, polytrauma patients pregnancy

Design outcomes

Primary

Measure	Time frame
Disability Rating Scale (DRS)	—

Secondary

Measure	Time frame
Galsco Coma Scale	—

Countries

Egypt

Contacts

Public ContactAhmad Yossef

assistant professor of Neurosurgery

ahmad.soliman@med.tanta.edu.eg+20403317928

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026